Delivery Order SPE2DB22D1106-SPE2DB25FEHF2
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD7WY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,045.32 firm fixed-price delivery order is for the medication Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of April 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,093.07 delivery order contract is for the provision of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,503.80, is for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. It is a firm-fixed-price delivery order contract with a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,525.95, is a delivery order for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025 and is a firm-fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,251.90 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $5,556.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,376.20 firm fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of August 9, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $90,960.77, is a delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has a performance period ending on April 21, 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $4,242.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, with a period of performance through April 2025. This contract is not set aside and is a firm fixed-price agreement. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
The federal contract award, with ID SPE2DB20D2104|SPE2DB25FMBWQ, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.12 firm fixed-price delivery order is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of November 14, 2024 and is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999...